News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Toby Eyre: R-Ibrutinib vs R-chemo as first line for Metastatic Cell Lymphoma
Toby Eyre/X
Nov 8, 2024, 15:14

Toby Eyre: R-Ibrutinib vs R-chemo as first line for Metastatic Cell Lymphoma

Toby Eyre, Specialist in Lymphoma CLL and Senior lecturer in University of Oxford, shared the post on X:

“ENRICH Primary analysis.

-4y follow up

-R-Ibrutinib vs R-chemo (BR or RCHOP) 1L MCL

-IR superior PFS to ICT HR 0.69 p=0.003

-Low haem toxicity

-Earlier increased QoL with R-Ibr

-Major benefit seen vs RCHOP subgroup

-1st 1L RCT across any lymphoma (not included CLL) showing non-chemo superior to ICT.”

 

Toby Eyre: R-Ibrutinib vs R-chemo as first line for Metastatic Cell Lymphoma

cancer ENRICH Metastatic Cell Lymphoma OncoDaily Oncology PFS R-chemo R-Ibrutinib Toby Eyre
Special Coverage
Blog
Nov 12, 2024, 15:01
Leading experts and advocates in the fight against lung cancer at Lung Cancer Workshop - MSD GCC
Blog
Nov 12, 2024, 14:55
Lissandra Dal Lago: Discussing Innovative endpoints for the development of new treatment strategies in Geriatric Oncology
Dialogues
Nov 12, 2024, 14:54
Beyond the Cancer Diagnosis: Dialogue with Clarissa Schilstra, Hosted by Adrian Pogacian
Blog
Nov 12, 2024, 14:41
OncoInfluencers to Follow on Social Media: Dr. Olubukola Ayodele
Opinion
Nov 12, 2024, 14:37
Douglas Flora: Embrace being a learner - it’s the best investment you can make in yourself
Societies
Nov 12, 2024, 14:36
Flavio Rocha - Candidate for ASCO Nominating Committee
Blog
Nov 12, 2024, 14:14
Gevorg Tamamyan: Register for the inaugural 3 days event of Global Cancer Movement
Career
Nov 12, 2024, 14:05
ECOG-ACRIN Announced the Recipients of the 2024 Scientific Leadership and Mentorship Awards
Blog
Nov 12, 2024, 13:44
James Gulley: First-in-class bispecific antibody that targets TCR Vbeta chain
Opinion
Nov 12, 2024, 13:40
Rahul Banerjee: Ensuring the safety of CARs at the 4th Annual APAC Cell Therapy Conference
Blog
Nov 12, 2024, 13:38
Shabnam Eghbali on Metastatic Melanoma treated with IO therapy - Vanderbilt Hem/Onc
Blog
Nov 12, 2024, 13:35
Petros Grivas: Highlighting Advancement in Immunotherapy and cutting-edge clinical trial innovations